Source comparison
Safety comparison
Feature Kisspeptin GnRH agonist hCG Site of action Hypothalamus (top) Pituitary (middle) Gonads (bottom) Half-life Very short (4 min for Kp-10) Short (minutes) Long (days) OHSS risk Lowest Lower than hCG Highest FDA approved No Yes (various forms) Yes Testicul
This comparison does not assign a generated winner or score.
- Feature
- Kisspeptin
- GnRH agonist
- hCG
- Site of action
- Hypothalamus (top)
- Pituitary (middle)
- Gonads (bottom)
- Half-life
- Very short (4 min for Kp-10)
- Short (minutes)
- Long (days)
- OHSS risk
- Lowest
- Lower than hCG
- Highest
- FDA approved
- No
- Yes (various forms)
- Yes
- Testicular atrophy risk
- Minimal (preserves axis)
- Minimal
- Low (direct stimulation)
- Tachyphylaxis
- Yes (with continuous use)
- For men using TRT who want to maintain fertility and testicular function, kisspeptin offers an interesting alternative to hCG.
- While hCG directly stimulates the testes, kisspeptin preserves the entire axis from top to bottom.
- The tradeoff is dosing frequency. hCG stays active for days. Kisspeptin requires daily or every-other-day administration to maintain consistent stimulation. SeekPeptides members can explore detailed protocol comparisons that account for these practical differences.